116 related articles for article (PubMed ID: 10812074)
1. Molecular chaperone properties of serum amyloid P component.
Coker AR; Purvis A; Baker D; Pepys MB; Wood SP
FEBS Lett; 2000 May; 473(2):199-202. PubMed ID: 10812074
[TBL] [Abstract][Full Text] [Related]
2. Structure of pentameric human serum amyloid P component.
Emsley J; White HE; O'Hara BP; Oliva G; Srinivasan N; Tickle IJ; Blundell TL; Pepys MB; Wood SP
Nature; 1994 Jan; 367(6461):338-45. PubMed ID: 8114934
[TBL] [Abstract][Full Text] [Related]
3. Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.
Ozawa D; Nomura R; Mangione PP; Hasegawa K; Okoshi T; Porcari R; Bellotti V; Naiki H
Sci Rep; 2016 Jul; 6():29077. PubMed ID: 27380955
[TBL] [Abstract][Full Text] [Related]
4. Antiamyloidogenic and proamyloidogenic chaperone effects of C-reactive protein and serum amyloid P component.
Ozawa D; Nomura R; Mangione PP; Hasegawa K; Okoshi T; Porcari R; Bellotti V; Naiki H
Amyloid; 2017 Mar; 24(sup1):28-29. PubMed ID: 28434325
[No Abstract] [Full Text] [Related]
5. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
Hohenester E; Hutchinson WL; Pepys MB; Wood SP
J Mol Biol; 1997 Jun; 269(4):570-8. PubMed ID: 9217261
[TBL] [Abstract][Full Text] [Related]
6. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
Ying SC; Gewurz AT; Jiang H; Gewurz H
J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
[TBL] [Abstract][Full Text] [Related]
7. Binding specificity of serum amyloid P component for the pyruvate acetal of galactose.
Hind CR; Collins PM; Renn D; Cook RB; Caspi D; Baltz ML; Pepys MB
J Exp Med; 1984 Apr; 159(4):1058-69. PubMed ID: 6707579
[TBL] [Abstract][Full Text] [Related]
8. Human serum amyloid P component is a single uncomplexed pentamer in whole serum.
Hutchinson WL; Hohenester E; Pepys MB
Mol Med; 2000 Jun; 6(6):482-93. PubMed ID: 10972085
[TBL] [Abstract][Full Text] [Related]
9. Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.
Aquilina JA; Robinson CV
Biochem J; 2003 Oct; 375(Pt 2):323-8. PubMed ID: 12892563
[TBL] [Abstract][Full Text] [Related]
10. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
Pepys MB; Herbert J; Hutchinson WL; Tennent GA; Lachmann HJ; Gallimore JR; Lovat LB; Bartfai T; Alanine A; Hertel C; Hoffmann T; Jakob-Roetne R; Norcross RD; Kemp JA; Yamamura K; Suzuki M; Taylor GW; Murray S; Thompson D; Purvis A; Kolstoe S; Wood SP; Hawkins PN
Nature; 2002 May; 417(6886):254-9. PubMed ID: 12015594
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of serum amyloid P from C4b-binding protein and other sites by lactic acid: potential role of lactic acid in the regulation of pentraxin function.
Evans TC; Nelsestuen GL
Biochemistry; 1995 Aug; 34(33):10440-7. PubMed ID: 7654697
[TBL] [Abstract][Full Text] [Related]
12. Chaperone-like activity of tubulin. binding and reactivation of unfolded substrate enzymes.
Manna T; Sarkar T; Poddar A; Roychowdhury M; Das KP; Bhattacharyya B
J Biol Chem; 2001 Oct; 276(43):39742-7. PubMed ID: 11509563
[TBL] [Abstract][Full Text] [Related]
13. Native human serum amyloid P component is a single pentamer.
Sørensen IJ; Andersen O; Nielsen EH; Svehag SE
Scand J Immunol; 1995 Mar; 41(3):263-7. PubMed ID: 7871385
[TBL] [Abstract][Full Text] [Related]
14. Artificial chaperone-assisted refolding of chemically denatured alpha-amylase.
Yazdanparast R; Khodagholi F; Khodarahmi R
Int J Biol Macromol; 2005 Jun; 35(5):257-63. PubMed ID: 15862864
[TBL] [Abstract][Full Text] [Related]
15. Calcium-dependent aggregation of human serum amyloid P component. Inhibition by the cyclic 4,6-pyruvate acetal of galactose.
Hind CR; Collins PM; Pepys MB
Biochim Biophys Acta; 1984 Nov; 802(1):148-50. PubMed ID: 6435685
[TBL] [Abstract][Full Text] [Related]
16. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
[TBL] [Abstract][Full Text] [Related]
17. A protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins.
Kinoshita CM; Gewurz AT; Siegel JN; Ying SC; Hugli TE; Coe JE; Gupta RK; Huckman R; Gewurz H
Protein Sci; 1992 Jun; 1(6):700-9. PubMed ID: 1304912
[TBL] [Abstract][Full Text] [Related]
18. Evidence for an extended interacting surface between beta-amyloid and serum amyloid P component.
Likó I; Mák M; Klement E; Hunyadi-Gulyás E; Pázmány T; Medzihradszky KF; Urbányi Z
Neurosci Lett; 2007 Jan; 412(1):51-5. PubMed ID: 17141957
[TBL] [Abstract][Full Text] [Related]
19. Binding of human serum amyloid P-component to phosphocholine.
Christner RB; Mortensen RF
Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
[TBL] [Abstract][Full Text] [Related]
20. Human serum amyloid P-component (SAP) selectively binds to immobilized or bound forms of C-reactive protein (CRP).
Swanson SJ; Christner RB; Mortensen RF
Biochim Biophys Acta; 1992 Dec; 1160(3):309-16. PubMed ID: 1477104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
